← Leaderboards
Joel Thomas Dudley
Icahn School Of Medicine At Mount Sinai
$4,550,063
Attributed
$7,346,498
Total exposure
10
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2013–19$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$9,217,140 · 11
By mechanism
R01$3,264,770 · 2
U54$3,113,284 · 4
UG3$853,963 · 1
R56$844,112 · 1
UH2$677,098 · 1
R34$366,497 · 1
Top collaborators
- Avi Ma'Ayan10 shared
- Irina V Budunova4 shared
- Gregory Paul Downey2 shared
- Samuel E Gandy2 shared
- Naftali Kaminski2 shared
- Michelle E Ehrlich1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Avi Ma'ayan$32,225,457
- Philip Martyn Robson$512,144
Others in their field
Top investigators on “Genome”
- Eric S Lander · Whitehead Institute For Biomedical Res$790,826,794
- Richard A Gibbs · Baylor College Of Medicine$661,700,875
- Richard K. Wilson · Washington University$497,388,134
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- David Heimbrook · Leidos Biomedical Research, Inc.$333,649,126
- Stacey Gabriel · Massachusetts Institute Of Technology$331,896,891
Research focus
GenomePharmaceutical PreparationsBaseComplexBiologyGenesAdverse EffectsLinkLiteratureProgramsDatabasesData SetMapsArchitectureDisease PhenotypeInnovationCommunitiesMolecularGenomicsInformation Resources ManagementPathway InteractionsFibrosisGenome-WideMolecular Profiling
Grant awards (24)
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis$97,416
UH3 · FY2019 · TR
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis$853,963
UG3 · FY2018 · TR
Pre-clinical Testing of a Novel Therapeutic for Nonalcoholic Steatohepatitis$338,549
UH2 · FY2018 · TR · contact PI
Integrated understanding of complex viral network biology in Alzheimer's Disease$844,112
R56 · FY2017 · AG · contact PI
Integrative informatics approach to develop safe glucocorticoid therapies$486,475
R01 · FY2017 · GM
Pre-clinical Testing of a Novel Therapeutic for Nonalcoholic Steatohepatitis$338,549
UH2 · FY2017 · TR · contact PI
Mount Sinai's Knowledge Management Center for Illuminating the Druggable Genome$66,000
U54 · FY2017 · CA
Mount Sinai's Knowledge Management Center for Illuminating the Druggable Genome$562,000
U54 · FY2016 · CA
Integrative informatics approach to develop safe glucocorticoid therapies$486,475
R01 · FY2016 · GM
Methods for Evolutionary Informed Network Analysis to Discover Disease Variation$414,562
R01 · FY2016 · DK · contact PI
Integrative informatics approach to develop safe glucocorticoid therapies$100,000
R01 · FY2016 · GM
Mount Sinai's Knowledge Management Center for Illuminating the Druggable Genome$621,321
U54 · FY2015 · CA
Integrative informatics approach to develop safe glucocorticoid therapies$516,794
R01 · FY2015 · GM
Methods for Evolutionary Informed Network Analysis to Discover Disease Variation$414,562
R01 · FY2015 · DK · contact PI
Data Organization Core$407,203
U54 · FY2015 · CA
User Interface Portal$121,681
U54 · FY2015 · CA
Administrative Core$92,437
U54 · FY2015 · CA
Mount Sinai's Knowledge Management Center for Illuminating the Druggable Genome$621,321
U54 · FY2014 · CA
Data Organization Core$449,160
U54 · FY2014 · CA
Methods for Evolutionary Informed Network Analysis to Discover Disease Variation$414,442
R01 · FY2014 · DK · contact PI
Network Based Predictive Drug Discovery for Alzheimer's Disease$366,497
R34 · FY2014 · AG · contact PI
Administrative Core$100,058
U54 · FY2014 · CA
User Interface Portal$72,103
U54 · FY2014 · CA
Methods for Evolutionary Informed Network Analysis to Discover Disease Variation$431,460
R01 · FY2013 · DK · contact PI